Starpharma Holdings Limited Stock News

Starpharma Holdings Limited (OTCMKTS:SPHRY) was the target of a large drop in short interest in November. As of November 30th, there was short interest totalling 700 shares, a drop of 46.2% from the November 15th total of 1,300 shares. Based on an average daily volume of 3,900 shares, the short-interest ratio is currently 0.2 days. []

Starpharma is complementing COVID-19 vaccines with its anti-viral nasal spray The post What is happening to the Starpharma (ASX:SPL) share price today? appeared first on The Motley Fool Australia .

The company''s shares are on the move today. The post Starpharma (ASX:SPL) share price shoots 6% higher on Roche agreement appeared first on The Motley Fool Australia .

Starpharma has signed a 5-year supply and distribution agreement for VIRALEZE in Vietnam The agreement includes a minimum commitment of 1 million units in the first year VIRALEZE is scheduled to be officially launched in Vietnam today, following its registration for sale this week VIRALEZE is a broad-spectrum antiviral nasal spray that contains SPL7013, which has been shown to have potent antiviral and virucidal activity in multiple respiratory viruses, including inactivation of >99.9% of the Delta variant of SARS-CoV-2, in laboratory studies that have been published in international, peer reviewed journals MELBOURNE, Australia , Dec. 3, 2021 /PRNewswire/ -- Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE antiviral nasal spray in Vietnam , with a minimum commitment of 1 million units in the first year. The official launch of VIRALEZE in Vietnam is scheduled to occur today and will be attended by key health officials, healthcare leaders, and media.

What''s happening with the biopharmaceutical company? The post Starpharma (ASX:SPL) share price climbs 3% on back of Vietnam launch appeared first on The Motley Fool Australia .

These ASX shares are on form on Wednesday The post Why Bellevue Gold, South32, Starpharma, and Tuas shares are pushing higher appeared first on The Motley Fool Australia .

It''s been a good day for this ASX healthcare share so far. Here are the details The post Starpharma (ASX:SPL) share price jumps 6% following AGM appeared first on The Motley Fool Australia .

MELBOURNE, Australia, Nov. 26, 2021 /PRNewswire/ -- Starpharma showed that 100% of evaluable patients with Stage IV prostate cancer have had efficacy responses, utilising one or more standard meas

Starpharma Holdings Limited (OTCMKTS:SPHRY)s stock price traded up 4.1% during trading on Monday . The company traded as high as $7.70 and last traded at $7.55. 3,410 shares traded hands during mid-day trading, an increase of 27% from the average session volume of 2,692 shares. The stock had previously closed at $7.25. The firms 50 []

The biotech company has been in the doldrums lately. The post Why is the Starpharma (ASX:SPL) share price trading at 52-week lows? appeared first on The Motley Fool Australia .

MELBOURNE, Australia, Sept. 15, 2021 /PRNewswire/ -- DEP® cabazitaxel is a proprietary nanoparticle version of leading prostate cancer drug cabazitaxel (Jevtana®), which had global sales of US$536

The delta variant of SARS-CoV-2 is changing the rules of engagement because it is highly infectious and it gets passed on rapidly.

Early-Stage Covid Treatment Prospects: Merck/Ridgeback Bio And Starpharma Lead The Pack

Starpharma Up With News, Down With None; Timing Entry Makes Sense

MELBOURNE, Australia, Feb. 11, 2021 /PRNewswire/ -- Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that is has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth